Navigation Links
Marque D. Todd, MS, DVM, DABT, Joins NDA Partners as Regulatory Toxicology Expert

NDA Partners Chairman Carl Peck, MD, announced today that Dr. Marque Todd, a regulatory toxicology expert with more than 20 years of experience working in the biopharmaceutical industry, has joined the firm as an Expert Consultant.

Dr. Todd has extensive experience with a variety of biologic modalities including monoclonal antibodies, bi-specific antibodies, Fc and other fusion proteins, antibody-drug conjugates, cytokines/interleukins, protein replacement therapies, nanoparticles, CAR-T cells, and vaccines. She also has extensive experience in developing diverse biotherapeutic modalities and small molecules for oncology. Dr. Todd has been involved in the preparation and submission of nonclinical sections of early and late stage regulatory documents including INDs and BLAs/NDAs and has participated in numerous successful health authority meetings.

Prior to joining NDA Partners, Dr. Todd was a Research Fellow at Pfizer and served as a Principal Scientist at Amgen and Chiron. In addition to her industry roles, Dr. Todd served as an Adjunct Professor with the University of California San Diego Extension, where she co-taught a course on nonclinical toxicology and drug development with sessions focused on the nonclinical development of biotherapeutics and oncology products.

“Dr. Todd’s extensive experience in developing diverse biotherapeutic modalities and small molecules for oncology, in addition to her experience with a variety of biologic modalities, will be a great resource for our clients developing biotherapeutic and oncology products,” said Dr. Peck. “We are pleased to welcome her to NDA Partners.”

Dr. Todd received her Doctor of Veterinary Medicine from Colorado State University and a master’s degree in Cancer Biology from Harvard School of Public Health, where she also completed postdoctoral work in molecular biology and immunology. Dr. Todd is a Diplomate of the American Board of Toxicology.

About NDA Partners
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Earle Martin, Chief Executive Officer
Office: 540-738-2550

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. Senior Regulatory Affairs and Program Management Executive, Robert Peterson, RAC, Joins NDA Partners
2. Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
3. Former OrthoLogic Quality Assurance Director, Donna Hartzfeld, PhD, Joins NDA Partners
4. Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
5. Former Vice President, Biometrics at GRAIL, Inc., Tara Maddala, PhD, Joins NDA Partners as Expert Consultant
6. Neal O’Farrell, Leading Cybersecurity Expert and Executive Director of the Identity Theft Council, Joins the Taliware™ Advisory Board
7. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
8. Aperio Clinical Outcomes Joins LaunchBio as an Innovation Partner
9. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
10. Barb Geiger, Former Executive Vice President of Clinical Development and Head of Global Oncology at Clinipace Inc., Joins NDA Partners as an Expert Consultant
11. Mike Cosgrove Joins Exalto Bearings UK
Post Your Comments:
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...
(Date:11/5/2019)... ... 2019 , ... Dr. Lauren Kopp celebrates one year ... WA, including porcelain veneers , smile makeovers, dental implants, and the Bioclear ... Dr. Kopp is passionate about serving her Seattle community with empathy and precision ...
(Date:10/30/2019)... ... October 30, 2019 , ... PathSensors, ... in Nashville, TN from Tuesday, November 5, 2019, to Thursday, November 7, 2019. ... biological, radiological, nuclear) and IED (explosive) threats. Delegates and experts from over 30 ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical ... with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs ... not informed of the latest data, potentially leading to patient risk. , By ...
(Date:10/30/2019)... CITY, S.D. (PRWEB) , ... October 30, 2019 , ... ... team of researchers and students at South Dakota School of Mines & Technology ... cancer cells while leaving healthy cells alive. , If successful, the technique would ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality ... Silver sponsorship and cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) ... Diego, California. , The Biomanufacturing World Summit brings together pharmaceutical executives, ...
(Date:10/22/2019)... ANGELES (PRWEB) , ... October 22, 2019 , ... nQ ... Graziadio Business School’s 2019 Most Fundable Companies List which was announced at a showcase ... than $10 million in annual revenue, strong business plans, and impressive near-term growth projections ...
Breaking Biology Technology: